BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36841365)

  • 1. ETS transcription factors: Multifaceted players from cancer progression to tumor immunity.
    Wang Y; Huang Z; Sun M; Huang W; Xia L
    Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188872. PubMed ID: 36841365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of ETS transcription factor-mediated tumorigenesis.
    Kar A; Gutierrez-Hartmann A
    Crit Rev Biochem Mol Biol; 2013; 48(6):522-43. PubMed ID: 24066765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E26 transformation (ETS)‑specific related transcription factor‑3 (ELF3) orchestrates a positive feedback loop that constitutively activates the MAPK/Erk pathway to drive thyroid cancer.
    Chen H; Chen W; Zhang X; Hu L; Tang G; Kong J; Wang Z
    Oncol Rep; 2019 Jan; 41(1):570-578. PubMed ID: 30365150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ETS transcription factors control transcription of EZH2 and epigenetic silencing of the tumor suppressor gene Nkx3.1 in prostate cancer.
    Kunderfranco P; Mello-Grand M; Cangemi R; Pellini S; Mensah A; Albertini V; Malek A; Chiorino G; Catapano CV; Carbone GM
    PLoS One; 2010 May; 5(5):e10547. PubMed ID: 20479932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signal transduction and the Ets family of transcription factors.
    Yordy JS; Muise-Helmericks RC
    Oncogene; 2000 Dec; 19(55):6503-13. PubMed ID: 11175366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Ets family of transcription factors.
    Wasylyk B; Hahn SL; Giovane A
    Eur J Biochem; 1993 Jan; 211(1-2):7-18. PubMed ID: 8425553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ELF3, ELF5, EHF and SPDEF Transcription Factors in Tissue Homeostasis and Cancer.
    Luk IY; Reehorst CM; Mariadason JM
    Molecules; 2018 Aug; 23(9):. PubMed ID: 30200227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ETS family transcription factors collaborate with alternative signaling pathways to induce carcinoma from adult murine prostate cells.
    Zong Y; Xin L; Goldstein AS; Lawson DA; Teitell MA; Witte ON
    Proc Natl Acad Sci U S A; 2009 Jul; 106(30):12465-70. PubMed ID: 19592505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ETV1, 4 and 5: an oncogenic subfamily of ETS transcription factors.
    Oh S; Shin S; Janknecht R
    Biochim Biophys Acta; 2012 Aug; 1826(1):1-12. PubMed ID: 22425584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ETS (E26 transformation-specific) up-regulation of the transcriptional co-activator TAZ promotes cell migration and metastasis in prostate cancer.
    Liu CY; Yu T; Huang Y; Cui L; Hong W
    J Biol Chem; 2017 Jun; 292(22):9420-9430. PubMed ID: 28408625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ets proteins in biological control and cancer.
    Hsu T; Trojanowska M; Watson DK
    J Cell Biochem; 2004 Apr; 91(5):896-903. PubMed ID: 15034925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Ets transcription factors of the PEA3 group: transcriptional regulators in metastasis.
    de Launoit Y; Baert JL; Chotteau-Lelievre A; Monte D; Coutte L; Mauen S; Firlej V; Degerny C; Verreman K
    Biochim Biophys Acta; 2006 Aug; 1766(1):79-87. PubMed ID: 16546322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteins of the ETS family with transcriptional repressor activity.
    Mavrothalassitis G; Ghysdael J
    Oncogene; 2000 Dec; 19(55):6524-32. PubMed ID: 11175368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of vascular inflammation and remodeling by ETS factors.
    Oettgen P
    Circ Res; 2006 Nov; 99(11):1159-66. PubMed ID: 17122446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular biology of the Ets family of transcription factors.
    Oikawa T; Yamada T
    Gene; 2003 Jan; 303():11-34. PubMed ID: 12559563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A transcriptional repressive role for epithelial-specific ETS factor ELF3 on oestrogen receptor alpha in breast cancer cells.
    Gajulapalli VN; Samanthapudi VS; Pulaganti M; Khumukcham SS; Malisetty VL; Guruprasad L; Chitta SK; Manavathi B
    Biochem J; 2016 Apr; 473(8):1047-61. PubMed ID: 26920025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signatures of DNA target selectivity by ETS transcription factors.
    Poon GMK; Kim HM
    Transcription; 2017 May; 8(3):193-203. PubMed ID: 28301293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of immunity-related genes in prostate cancer and potential role of the ETS family of transcription factors in their regulation.
    Adler D; Lindstrot A; Ellinger J; Rogenhofer S; Buettner R; Wernert N
    Int J Mol Med; 2011 Nov; 28(5):799-807. PubMed ID: 21833467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ETS transcription factors in endocrine systems.
    Gutierrez-Hartmann A; Duval DL; Bradford AP
    Trends Endocrinol Metab; 2007; 18(4):150-8. PubMed ID: 17387021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of CHK1 by ETS Family Members Promotes DNA Damage Response Bypass and Tumorigenesis.
    Lunardi A; Varmeh S; Chen M; Taulli R; Guarnerio J; Ala U; Seitzer N; Ishikawa T; Carver BS; Hobbs RM; Quarantotti V; Ng C; Berger AH; Nardella C; Poliseno L; Montironi R; Castillo-Martin M; Cordon-Cardo C; Signoretti S; Pandolfi PP
    Cancer Discov; 2015 May; 5(5):550-63. PubMed ID: 25653093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.